Abdominal Obesity, Cardiovascular Inflammation, and Effects of Growth Hormone Releasing Hormone Analogue

NCT01632592 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No funding available

Conditions

Abdominal Obesity

Interventions

DRUG: Tesamorelin
DRUG: Placebo

Sponsor

Massachusetts General Hospital